Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

NCT01649427 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics Study in de Novo Kidney Transplantation

Interventions

DRUG: Prograf
DRUG: Tacrolimus Hexal

Sponsor

Novartis Pharmaceuticals